Li Tao
About Li Tao
Li Tao is a Research Investigator at Bristol-Myers Squibb in New Brunswick, NJ, with a background in Pharmaceutical Sciences and extensive experience in formulation development and CMC activities.
Professional Role at Bristol-Myers Squibb
Li Tao is currently employed at Bristol-Myers Squibb as a Research Investigator. Stationed in New Brunswick, NJ, Tao's role involves coordination across various departments including Materials Sciences, AR&D, Crystal engineering, DMPK, and Regulatory CMC. Responsibilities include leading project teams, developing formulations for Phase I and II clinical studies, and supporting product development until launch.
Previous Experience at Lavipharm
Before joining Bristol-Myers Squibb, Li Tao worked as a Research Scientist at Lavipharm. During the period from 1998 to 1999 in Piscataway, NJ, Tao's role focused on preformulation studies, formulation technical challenges, and process development.
Advanced Education at Rutgers University
Li Tao pursued a Ph.D. in Pharmaceutical Sciences at Rutgers, The State University of New Jersey-New Brunswick from 2000 to 2005. This advanced education equipped Tao with expertise necessary for leading complex pharmaceutical research and development initiatives.
Foundational Education at Shenyang Pharmaceutical University
Li Tao earned an M.S. in Pharmaceutical Sciences from Shenyang Pharmaceutical University. Studying from 1989 to 1996, this education laid a solid foundation for Tao's extensive career in pharmaceutical research and development.
Contributions to IND Filing
Li Tao has authored pharmaceutics sections in the CMC package for IND filing. This role included the development of compositions suitable for pharmacokinetic and toxicology studies, establishing usage criteria, and addressing formulation-related technical issues such as solubilization and chemical incompatibility.